ARMISTICE CAPITAL LLC 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 9:55 pm Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | ARMISTICE CAPITAL LLC | 0 0.000% | -2,742,000 (Position Closed) | Filing |
| 2021-02-16 2:47 pm Purchase | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | ARMISTICE CAPITAL LLC | 2,742,000 9.600% | 546,000 (+24.86%) | Filing |